Professor Elio Riboli is Chair in Cancer Epidemiology and Prevention and was formerly the Director of the School of Public Health at Imperial College London, rated one of the top two epidemiology and public health submissions to the UK’s Research Assessment Exercise (RAE) in 2009. He holds an M.D. degree (1977, State University of Milan), a Master of Public Health (1980, Milan) and a Master of Science in Epidemiology (1982, Harvard University). Professor Riboli is a Registered Physician (General Medical Council, UK, 2005) and an Honorary Fellow of the Royal College of Physicians (2008).
From 1983 to 2005 Professor Riboli was based at Lyon’s the International Agency for Research on Cancer (IARC), where he developed new research projects in the areas of nutrition, nutritional status and cancer. In 1989 he initiated the European Prospective Investigation into Cancer and Nutrition (EPIC), which sampled data from 500,000 subjects across 26 centres in ten countries. He was Head of the Nutrition and Hormones Group of IARC from 2004 to 2005.
Professor Riboli has co-authored over 310 peer-reviewed publications and over 100 book chapters and books and serves on editorial boards of major journals on nutrition, cancer and epidemiology.
In 2005 he joined Imperial College London as Professor of Cancer Epidemiology; in 2006 he was appointed Divisional Head of Epidemiology, Public Health and Primary Care, which later become the School of Public Health. Professor Riboli stepped down as Head of the School at the end of 2017.
et al., 2021, Genetically predicted circulating concentrations of micro-nutrients and risk of breast cancer: A Mendelian randomization study, International Journal of Cancer, Vol:148, ISSN:0020-7136, Pages:646-653
et al., 2021, Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction., Nat Genet
et al., 2021, GWAS of allometric body-shape indices in UK Biobank identifies loci associated with morphogenesis, organogenesis, adrenal cell renewal and various cancers, Scientific Reports, ISSN:2045-2322
et al., 2021, Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score, Bmc Medicine, Vol:19, ISSN:1741-7015
et al., 2021, Plasma Vitamin C and Type 2 Diabetes: Genome-Wide Association Study and Mendelian Randomization Analysis in European Populations, Diabetes Care, Vol:44, ISSN:0149-5992, Pages:98-106